Can oliceridine (TRV130), an ideal novel μ receptor G protein pathway selective (µ-GPS) modulator, provide analgesia without opioid-related adverse reactions?

Autor:	Hwoe Gyeong Ok1, Su Young Kim1 pain@pusan.ac.kr, Su Jung Lee1, Tae Kyun Kim1, Huh, Billy K.2, Kyung Hoon Kim1
Zdroj:	Korean Journal of Pain. Apr2018, Vol. 31 Issue 2, p73-79. 7p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu